Literature DB >> 31851354

Exploring Mechanistic Toxicity of Mixtures Using PBPK Modeling and Computational Systems Biology.

Patricia Ruiz1, Claude Emond2, Evad D McLanahan3, Shivanjali Joshi-Barr4, Moiz Mumtaz1.   

Abstract

Mixtures risk assessment needs an efficient integration of in vivo, in vitro, and in silico data with epidemiology and human studies data. This involves several approaches, some in current use and others under development. This work extends the Agency for Toxic Substances and Disease Registry physiologically based pharmacokinetic (PBPK) toolkit, available for risk assessors, to include a mixture PBPK model of benzene, toluene, ethylbenzene, and xylenes. The recoded model was evaluated and applied to exposure scenarios to evaluate the validity of dose additivity for mixtures. In the second part of this work, we studied toluene, ethylbenzene, and xylene (TEX)-gene-disease associations using Comparative Toxicogenomics Database, pathway analysis and published microarray data from human gene expression changes in blood samples after short- and long-term exposures. Collectively, this information was used to establish hypotheses on potential linkages between TEX exposures and human health. The results show that 236 genes expressed were common between the short- and long-term exposures. These genes could be central for the interconnecting biological pathways potentially stimulated by TEX exposure, likely related to respiratory and neuro diseases. Using publicly available data we propose a conceptual framework to study pathway perturbations leading to toxicity of chemical mixtures. This proposed methodology lends mechanistic insights of the toxicity of mixtures and when experimentally validated will allow data gaps filling for mixtures' toxicity assessment. This work proposes an approach using current knowledge, available multiple stream data and applying computational methods to advance mixtures risk assessment. Published by Oxford University Press on behalf of the Society of Toxicology 2019. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  PBPK; VOCs; computational systems biology; enrichment analysis; toxicogenomics

Mesh:

Substances:

Year:  2020        PMID: 31851354      PMCID: PMC8215597          DOI: 10.1093/toxsci/kfz243

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  32 in total

1.  Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants--metals.

Authors:  P Ruiz; B A Fowler; J D Osterloh; J Fisher; M Mumtaz
Journal:  SAR QSAR Environ Res       Date:  2010-10       Impact factor: 3.000

2.  Characteristics and health effects of BTEX in a hot spot for urban pollution.

Authors:  Mansooreh Dehghani; Mehdi Fazlzadeh; Armin Sorooshian; Hamid Reza Tabatabaee; Mohammad Miri; Abbas Norouzian Baghani; Mahdieh Delikhoon; Amir Hossein Mahvi; Majid Rashidi
Journal:  Ecotoxicol Environ Saf       Date:  2018-03-03       Impact factor: 6.291

3.  Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling.

Authors:  James E Dennison; Philip L Bigelow; Moiz M Mumtaz; Melvin E Andersen; Ivan D Dobrev; Raymond S H Yang
Journal:  J Occup Environ Hyg       Date:  2005-03       Impact factor: 2.155

4.  Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.

Authors:  Todd C Carpenter; William Schroeder; Kurt R Stenmark; Eric P Schmidt
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

5.  PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.

Authors:  Asoka Banno; Aravind T Reddy; Sowmya P Lakshmi; Raju C Reddy
Journal:  Nucl Receptor Res       Date:  2017-12-11

6.  Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans.

Authors:  R Tardif; S Laparé; G Charest-Tardif; J Brodeur; K Krishnan
Journal:  Risk Anal       Date:  1995-06       Impact factor: 4.000

7.  Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures.

Authors:  Claude Emond; Patricia Ruiz; Moiz Mumtaz
Journal:  Toxicol Appl Pharmacol       Date:  2016-12-10       Impact factor: 4.219

8.  Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents.

Authors:  I Lundberg; R Milatou-Smith
Journal:  Scand J Work Environ Health       Date:  1998-08       Impact factor: 5.024

9.  Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).

Authors:  M Moiz Mumtaz; Meredith Ray; Susan R Crowell; Deborah Keys; Jeffrey Fisher; Patricia Ruiz
Journal:  J Toxicol Environ Health A       Date:  2012

10.  Accessing an Expanded Exposure Science Module at the Comparative Toxicogenomics Database.

Authors:  Cynthia J Grondin; Allan Peter Davis; Thomas C Wiegers; Jolene A Wiegers; Carolyn J Mattingly
Journal:  Environ Health Perspect       Date:  2018-01-18       Impact factor: 9.031

View more
  3 in total

1.  Using the Key Characteristics of Carcinogens to Develop Research on Chemical Mixtures and Cancer.

Authors:  Cynthia V Rider; Cliona M McHale; Thomas F Webster; Leroy Lowe; William H Goodson; Michele A La Merrill; Glenn Rice; Lauren Zeise; Luoping Zhang; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2021-03-30       Impact factor: 9.031

2.  Evaluation of Inhalation Exposures and Potential Health Impacts of Ingredient Mixtures Using in vitro to in vivo Extrapolation.

Authors:  Jingjie Zhang; Xiaoqing Chang; Tessa L Holland; David E Hines; Agnes L Karmaus; Shannon Bell; K Monica Lee
Journal:  Front Toxicol       Date:  2022-02-02

Review 3.  The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.

Authors:  Zhengying Zhou; Jinwei Zhu; Muhan Jiang; Lan Sang; Kun Hao; Hua He
Journal:  Pharmaceutics       Date:  2021-05-12       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.